Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?Markella Konstantinidou, Alexander Dömlingꝉ, Tryfon Zarganes‐Tzitzikas et al.|Angewandte Chemie International Edition|2017Cited by 133
Human and mouse PD-L1: similar molecular structure, but different druggability profilesKatarzyna Magiera‐Mularz, Łukasz Skalniak|iScience|2020Cited by 106
Der Immuncheckpoint PD‐1/PD‐L1: Gibt es Therapieoptionen jenseits der Antikörper?Markella Konstantinidou, Alexander Dömlingꝉ, Tryfon Zarganes‐Tzitzikas et al.|Angewandte Chemie|2017Cited by 4